Chikungunya fever
Arbovirus/imported · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Mosquito-borne (Aedes) alphavirus causing abrupt high fever with severe, often incapacitating symmetrical polyarthralgia and rash. Endemic in Africa, Asia, the Americas and returning travellers.
Red flags
- Neurological involvement (encephalitis) - rare but serious
- Haemorrhage or shock (reconsider dengue)
- Severe disease in neonates and elderly with comorbidity
Assessment
Differential diagnosis
- Dengue
- Zika virus
- Malaria
- Acute viral arthritis (other)
- Reactive/seronegative arthritis
Investigations
- RT-PCR (early, first week) and serology (IgM after ~5 days)
- FBC (lymphopenia, mild thrombocytopenia), LFTs
- Malaria film/RDT and dengue testing to exclude co-endemic infections
- CRP
Management
- Confirm and exclude dengue and malaria (management differs and co-infection occurs)
- Rest, oral rehydration and paracetamol for fever/pain
- Avoid NSAIDs/aspirin until dengue is excluded (bleeding risk)
- Analgesia and physiotherapy advice for arthralgia
- Advise mosquito-bite avoidance to prevent onward transmission
Drugs & doses
Paracetamol for fever and pain
NSAIDs for arthralgia only after dengue excluded
Oral rehydration
Disposition
Mostly outpatient supportive care; admit only for severe/atypical disease or vulnerable patients.
Complications & pitfalls
- Chronic persistent arthralgia/arthritis lasting months
- Rare neurological and cardiac involvement
- Severe disease at extremes of age
Exam pearls
- Severe, prolonged symmetrical joint pain distinguishes chikungunya from dengue.
- Withhold NSAIDs until dengue is excluded because of bleeding risk.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.